Tina Deyhim, M.D., M.P.H.

Tina Deyhim completed her medical education in Iran, where she developed a strong interest in inflammatory bowel disease (IBD) and conducted research in this area. In 2023, she joined the IBD group at Beth Israel Deaconess Medical Center (BIDMC), where she had the privilege of contributing to multiple clinical trials, including the OPTIMIZE and BEST studies. She is currently an Internal Medicine resident at Lahey hospital and an aspiring gastroenterologist, with a continued research focus on therapeutic drug monitoring (TDM) and the advancement of personalized treatment strategies for patients with IBD.